Unusual effect of myo-inositol on phospholipid biosynthesis in Cryptococcus neoformans

References

1. Atkinson K.D. 1984; Saccharomjces cerevisiae recessive suppressor that circumvents phosphatidylserine deficiency. Genetics 108:533–543
   [Google Scholar]
2. Bailis A.M., Poole M.A., Carman G.M., Henry S.A. 1987; The membrane-associated enzyme phosphatidylserine synthase is regulated at the level of mRNA abundance. Mol Cell Biol 7:167–176
   [Google Scholar]
3. Barnett J. 1976; The utilization of sugars by yeasts. Adv Carbohydr Chem Biochem 32:125–234
   [Google Scholar]
4. Berridge M.J., Irvine R.F. 1984; Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature 312:315–320
   [Google Scholar]
5. Bhattacharjee A.K., Kwon-Chung K.J., Glaudemans C.P.J. 1979; The structure of the capsular polysaccharide from Cryptococcus neoformans serotype D. Carbohydr Res 73:183–192
   [Google Scholar]
6. Buede R., Rinker-Schaffer C., Pinto W.J., Lester R.L., Dickson R. 1991; Cloning and characterization of LCB1, a Saccharomycesgene required for biosynthesis of the long-chain base component of sphingolipids. J Bacteriol 173:4325–4332
   [Google Scholar]
7. Bulmer G.S., Sans M.D., Gunn C.M. 1967; Cryptococcus neoformans. I. Nonencapsulated mutants. J Bacteriol 94:1475–1479
   [Google Scholar]
8. Carman G.M., Henry S.A. 1989; Phospholipid biosynthesis in yeast. Annu Rev Biochem 58:635–669
   [Google Scholar]
9. Clark R.A., Greer D., Atkinson W., Valainis G.T., Hyslop N. 1990; Spectrum of Cryptococcus neoformans infections in 68 patients infected with human immunodeficiency virus. Rev Infect Dis 12:768–777
   [Google Scholar]
10. Cross G.A.M. 1990; Glycolipid anchoring of plasma membrane proteins. Annu Rev Cell Biol 6:1–39
    [Google Scholar]
11. Culbertson M.R., Donahue T.F., Henry S.A. 1976; Control of inositol biosynthesis in Saccharomyces cerevisiae: properties of a repressible enzyme system in extracts of wild-type (INO⁺ ) cells. J Bacteriol 126:232–242
    [Google Scholar]
12. Dickson R.C., Wells J.B., Schmidt A., Lester R.L. 1990; Isolation of mutant Saccharomyces cerevisiae strains that survive without sphingolipids. Mol Cell Biol 10:2176–2181
    [Google Scholar]
13. Dykstra M.A., Friedman L., Murphy J.W. 1977; Capsule size of Cryptococcus neoformans: control and relationship to virulence. Infect Immun 15:129–135
    [Google Scholar]
14. Fernandez S., Homann M.J., Henry S.A., Carman G.M. 1986; Metabolism of the phospholipid precursor inositol and its relationship to growth and viability in the natural auxotroph Schiyosaccharomyces pombe. J Bacteriol 166:779–786
    [Google Scholar]
15. Fromtling R.A., Shadomy H.J., Jacobson E.S. 1982; Decreased virulence in stable, acapsular mutants of Cryptococcus neoformans. Mycopathologia 79:23–29
    [Google Scholar]
16. Greenberg M.L., Goldwasser P., Henry S.A. 1982; Regulatory mutants of inositol biosynthesis in yeast: isolation of inositol excreting mutants. Genetics 100:19–33
    [Google Scholar]
17. Hill J.E., Chung C., McGraw P., Summers E., Henry S.A. 1990; Biosynthesis and the role of phospholipids in yeast membranes. In Biochemistry of Cell Walls and Membranes in Fungi pp. 245–260 Kuhn P.J., Trinci A.P.J., Jung M.L., Goosen M.W., Coping L.G. Edited by Berlin:: Springer-Verlag.;
    [Google Scholar]
18. Hokin M.E., Hokin L.E. 1953; Enzyme secretion and the incorporation of P³² into phospholipids of pancreas slices. J Biol Chem 203:967–977
    [Google Scholar]
19. Itoh T., Kaneko H. 1977; The in vivo incorporation of ³²P-labelled orthophosphate into pyrophosphatidic acid and other phospholipids of Cryptococcus neoformans through cell growth. Lipids 12:810–813
    [Google Scholar]
20. Itoh T., Waki H., Kaneko H. 1975; Changes of lipid composition with growth phase of Cryptococcus neoformans. Agric Biol Chem 39:2365–2371
    [Google Scholar]
21. Jacobson E.S., Emery H.S. 1991; Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J Bacteriol 173:401–403
    [Google Scholar]
22. Jacobson E.S., Ayers D.J., Harrell A.C., Nicholas C.C. 1982; Genetic and phenotypic characterization of capsule mutants of Cryptococcus neoformans. J Bacteriol 150:1292–1296
    [Google Scholar]
23. Kelley M.J., Bailis A.M., Henry S.A., Carmen G. 1988; Regulation of phospholipid biosynthesis in Saccharomyces cerevisiaeby inositol: inositol is an inhibitor of phosphatidylserine synthase activity. J Biol Chem 263:18078–18085
    [Google Scholar]
24. Kennedy E.P., Weiss S.B. 1956; The function of cytidine coenzyme in the biosynthesis of phospholipids. J Biol Chem 222:193–214
    [Google Scholar]
25. Klig L.S., Homann M.J., Carman G.M., Henry S.A. 1985; Coordinate regulation of phospholipid biosynthesis in Saccharomyces cerevisiae: pleiotropically constitutive opi1 mutant. J Bacteriol 162:1135–1141
    [Google Scholar]
26. Klig L.S., Homann M.J., Kohlwein S.D., Kelley M.J., Henry S.A., Carman G.M. 1988; Saccharomyces cerevisiae mutant with a partial defect in synthesis of CDP-diacylglycerol and altered regulation of phospholipid biosynthesis. J Bacteriol 170:1878–1886
    [Google Scholar]
27. Klig L.S., Friedli L., Schmid E. 1990; Phospholipid biosynthesis in Candida albicans: regulation by the precursor inositol and choline. J Bacteriol 172:4407–4414
    [Google Scholar]
28. Konemane W., Roberts G.D. 1985; Preliminary identification of fungal cultures. In Practical Laboratory Mycology p. 152 Baltimore, MD:: Williams and Williams.;
    [Google Scholar]
29. Kozel T.R. 1977; Non-encapsulated variant of Cryptococcus neoformans. II. Surface receptors for cryptococcal polysaccharide and their role in inhibition of phagocytosis by polysaccharide. Infect Immun 16:99–106
    [Google Scholar]
30. Kozel T.R., Cazin J. Jr 1971; Nonencapsulated variant of Cryptococcus neoformans. I. Virulence studies and characterization of soluble polysaccharide. Infect Immun 3:286–294
    [Google Scholar]
31. Kozel T.R., Mastroianni R.P. 1976; Inhibition of phagocytosis by cryptococcal polysaccharide: dissociation of the attachment and ingestion phases of phagocytosis. Infect Immun 14:62–67
    [Google Scholar]
32. Kwon-Chung K.J., Bennett J.E. 1978; Distribution of a and a mating types of Cryptococus neoformans among natural and clinical isolates. Am J Epidemiol 108:337–340
    [Google Scholar]
33. Kwon-Chung K.J., Bennett J.E. 1992; Cryptococcosis. In Medical Mycology pp. 397–446 Cann C. Edited by Philadelphia:: Lea and Febiger.;
    [Google Scholar]
34. Kwon-Chung K.J., Edman J.C. 1992; Recent advances in the molecular genetics of Cryptococcus neoformans. . In Frontiers of Infectious Disease: New Strategies in Fungal Disease pp. 195–207 Bennett J.E., Hay R., Peterson P.K. Edited by New York:: Churchill Livingston.;
    [Google Scholar]
35. Kwon-Chung K.J., Rhodes J.C. 1986; Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 51:218–223
    [Google Scholar]
36. Kwon-Chung K.J., Polacheck I., Popkins T. 1982; Melanin-lacking mutants of Cryptococcus neoformans and their virulence in mice. J Bacteriol 150:1414–1421
    [Google Scholar]
37. Kwon-Chung K.J., Edman J.C., Wickes B.L. 1992; Genetic association of mating types and virulence in Cryptococcus neoformans. Infect Immun 60:602–605
    [Google Scholar]
38. Moore T.D.E., Edman J.C. 1993; The α-mating type locus of Cryptococcus neoformans contains a peptide pheromone gene. Mol Cell Biol 13:1962–1970
    [Google Scholar]
39. Musial C.E., Cockerill F.R. III Roberts G.D. 1988; Fungal infections of the immunocompromised host: clinical and laboratory aspects. Clin Microbiol Rev 1:349–364
    [Google Scholar]
40. Odds F.C. 1987; Candida infections: an overview. CRC Crit Rev Microbiol 15:1–5
    [Google Scholar]
41. Olivera A., Buckley N.E., Spiegel S. 1992; Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J Biochem Mol Biol 267:26126–26127
    [Google Scholar]
42. Paulus H., Kennedy E.P. 1960; The enzymatic synthesis of inositol monophosphatide. J Biol Chem 235:1303–1311
    [Google Scholar]
43. Pinto W.J., Srinivasan B., Shepherd S., Schmidt A., Dickson R.C., Lester R.L. 1992; Sphingolipid long-chain-base auxo- trophs of Saccharomyces cerevisiae: genetics, physiology, and a method for their selection. J Bacteriol 174:2565–2574
    [Google Scholar]
44. Polacheck I., Hearing V.I., Kwon-Chung K.J. 1982; Biochemical studies of phenoloxidase and utilization of catecholamine in Cryptococcus neoformans. J Bacteriol 150:1212–1220
    [Google Scholar]
45. Polacheck I., Platt Y., Aronovitch J. 1990; Catecholamine and virulence of Cryptococcus neoformans. Infect Immun 58:2919–2922
    [Google Scholar]
46. Poole M.A., Homann M.J., Bae-Lee M.S., Carman G.M. 1986; Regulation of phosphatidylserine synthase from Saccharomyces cerevisiae by phospholipid precursors. J Bacteriol 168:668–672
    [Google Scholar]
47. Randhawa R.E., Paliwal D.K. 1979; Survey of Cryptococcus neoformans in the respiratory tract of patients with bronchopulmonary disorders and in the air. Sabouraudia 17:399–404
    [Google Scholar]
48. Rawat D.S., Upreti H.B., Das S.K. 1984; Lipid composition of Cryptococcus neoformans. Microbiologica 7:299–307
    [Google Scholar]
49. Rhodes J.C., Polacheck I., Kwon-Chung K.J. 1982; Phenoloxidase activity and virulence in isogenic strains of Cryptococcus neoformans. Infect Immun 36:1175–1184
    [Google Scholar]
50. Smith S.W., Lester R.L. 1974; Inositol phosphorylceramide, a novel substance and the chief member of a major group of yeast sphingolipids containing a single inositol phosphate. J Biol Chem 249:3395–3405
    [Google Scholar]
51. Spector R. 1976; Inositol accumulation by brain slices in vitro. J Neurochem 27:1273–1276
    [Google Scholar]
52. Spector R., Lorenzo A.V. 1975; myo-Inositol transport in the central nervous system. Am J Physiol 228:1510–1518
    [Google Scholar]
53. Steiner S., Lester R.L. 1972; Studies on the diversity of inositol-containing yeast phospholipids: incorporation of 2-de-oxyglucose into lipid. J Bacteriol 109:81–88
    [Google Scholar]
54. Steiner S., Smith S., Waechter C.J., Lester R.L. 1969; Isolation and partial characterization of a major inositol-containing lipid in baker̓s yeast, mannosyl-diinositol, diphosphoryl-ceramide. Proc Natl Acad Sci USA 64:1042–1048
    [Google Scholar]
55. Waechter C.J., Lester R.L. 1973; Differential regulation of the N-methyltransferases responsible for phosphatidylcholine synthesis in Saccharomyces cerevisiae. Arch Biochem Biophys 158:401–410
    [Google Scholar]
56. Wang Y., Casadevall A. 1994; Susceptibility of melanized and nonmelanized Cryptococcus neoformans to nitrogen- and oxygen- derived oxidants. Infect Immun 62:3004–3007
    [Google Scholar]
57. Yamashita S., Oshima A., Nikawa J.I., Hosaka K. 1982; Regulation of the phosphatidylethanolamine methylation pathway in Saccharomyces cerevisiae. Eur J Biochem 128:589–595
    [Google Scholar]